Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Current understandings about cognition and the neurobiological correlates in schizophrenia.

Kar SK, Jain M.

J Neurosci Rural Pract. 2016 Jul-Sep;7(3):412-8. doi: 10.4103/0976-3147.176185. Review.

2.

Validation of a Computerized test of Functional Capacity.

Keefe RS, Davis VG, Atkins AS, Vaughan A, Patterson T, Narasimhan M, Harvey PD.

Schizophr Res. 2016 Aug;175(1-3):90-6. doi: 10.1016/j.schres.2016.03.038. Epub 2016 Apr 16.

3.

A longitudinal investigation of childhood communication ability and adolescent psychotic experiences in a community sample.

Sullivan SA, Hollen L, Wren Y, Thompson AD, Lewis G, Zammit S.

Schizophr Res. 2016 May;173(1-2):54-61. doi: 10.1016/j.schres.2016.03.005. Epub 2016 Mar 10.

4.

History of the Concept of Disconnectivity in Schizophrenia.

Coyle JT, Balu DT, Puhl MD, Konopaske GT.

Harv Rev Psychiatry. 2016 Mar-Apr;24(2):80-6. doi: 10.1097/HRP.0000000000000102.

PMID:
26954593
5.

Factor structure of cognition and functional capacity in two studies of schizophrenia and bipolar disorder: Implications for genomic studies.

Harvey PD, Aslan M, Du M, Zhao H, Siever LJ, Pulver A, Gaziano JM, Concato J.

Neuropsychology. 2016 Jan;30(1):28-39. doi: 10.1037/neu0000245.

PMID:
26710094
6.

Social cognition as an RDoC domain.

Gur RC, Gur RE.

Am J Med Genet B Neuropsychiatr Genet. 2016 Jan;171B(1):132-41. doi: 10.1002/ajmg.b.32394. Epub 2015 Nov 26. Review.

PMID:
26607670
7.

Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia.

Keefe RS, Haig GM, Marder SR, Harvey PD, Dunayevich E, Medalia A, Davidson M, Lombardo I, Bowie CR, Buchanan RW, Bugarski-Kirola D, Carpenter WT, Csernansky JT, Dago PL, Durand DM, Frese FJ, Goff DC, Gold JM, Hooker CI, Kopelowicz A, Loebel A, McGurk SR, Opler LA, Pinkham AE, Stern RG.

Schizophr Bull. 2016 Jan;42(1):19-33. doi: 10.1093/schbul/sbv111. Epub 2015 Sep 11.

8.

Brain structure and function correlates of cognitive subtypes in schizophrenia.

Geisler D, Walton E, Naylor M, Roessner V, Lim KO, Charles Schulz S, Gollub RL, Calhoun VD, Sponheim SR, Ehrlich S.

Psychiatry Res. 2015 Oct 30;234(1):74-83. doi: 10.1016/j.pscychresns.2015.08.008. Epub 2015 Aug 21.

PMID:
26341950
9.

Memory systems in schizophrenia: Modularity is preserved but deficits are generalized.

Haut KM, Karlsgodt KH, Bilder RM, Congdon E, Freimer NB, London ED, Sabb FW, Ventura J, Cannon TD.

Schizophr Res. 2015 Oct;168(1-2):223-30. doi: 10.1016/j.schres.2015.08.014. Epub 2015 Aug 20.

PMID:
26299707
10.

Social Cognition Psychometric Evaluation: Results of the Initial Psychometric Study.

Pinkham AE, Penn DL, Green MF, Harvey PD.

Schizophr Bull. 2016 Mar;42(2):494-504. doi: 10.1093/schbul/sbv056. Epub 2015 May 4. Erratum in: Schizophr Bull. 2016 Sep;42(5):1304.

PMID:
25943125
11.

Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB).

McCleery A, Green MF, Hellemann GS, Baade LE, Gold JM, Keefe RS, Kern RS, Mesholam-Gately RI, Seidman LJ, Subotnik KL, Ventura J, Nuechterlein KH.

Psychol Med. 2015;45(12):2657-66. doi: 10.1017/S0033291715000641. Epub 2015 Apr 28. Erratum in: Psychol Med. 2016 Apr;46(5):1119.

12.

Determinants of different aspects of everyday outcome in schizophrenia: The roles of negative symptoms, cognition, and functional capacity.

Strassnig MT, Raykov T, O'Gorman C, Bowie CR, Sabbag S, Durand D, Patterson TL, Pinkham A, Penn DL, Harvey PD.

Schizophr Res. 2015 Jun;165(1):76-82. doi: 10.1016/j.schres.2015.03.033. Epub 2015 Apr 11.

13.

The "Right Stuff" Revisited: What Have We Learned About the Determinants of Daily Functioning in Schizophrenia?

Green MF, Llerena K, Kern RS.

Schizophr Bull. 2015 Jul;41(4):781-5. doi: 10.1093/schbul/sbv018. Epub 2015 Mar 7.

14.

Clinical predictors of therapeutic response to antipsychotics in schizophrenia.

Carbon M, Correll CU.

Dialogues Clin Neurosci. 2014 Dec;16(4):505-24. Review.

15.

Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study.

Kumar S, Chaudhury S.

Ind Psychiatry J. 2014 Jan;23(1):27-35. doi: 10.4103/0972-6748.144953.

16.

Comparison of auditory and visual oddball fMRI in schizophrenia.

Collier AK, Wolf DH, Valdez JN, Turetsky BI, Elliott MA, Gur RE, Gur RC.

Schizophr Res. 2014 Sep;158(1-3):183-8. doi: 10.1016/j.schres.2014.06.019. Epub 2014 Jul 15.

17.

Attitudes toward Medication and Reasons for Non-Compliance in Patients with Schizophrenia.

Chandra IS, Kumar KL, Reddy MP, Reddy CM.

Indian J Psychol Med. 2014 Jul;36(3):294-8. doi: 10.4103/0253-7176.135383.

18.

Association between schizophrenia symptoms and neurocognition on mobility in older adults with schizophrenia.

Leutwyler H, Hubbard E, Jeste D, Miller B, Vinogradov S.

Aging Ment Health. 2014;18(8):1006-12. doi: 10.1080/13607863.2014.903467. Epub 2014 Apr 4.

19.

The relationship between executive functions and fluid intelligence in schizophrenia.

Roca M, Manes F, Cetkovich M, Bruno D, Ibáñez A, Torralva T, Duncan J.

Front Behav Neurosci. 2014 Feb 24;8:46. doi: 10.3389/fnbeh.2014.00046. eCollection 2014.

20.

Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia.

Boggs DL, Carlson J, Cortes-Briones J, Krystal JH, D'Souza DC.

Curr Pharm Des. 2014;20(31):5077-92. Review.

Items per page

Supplemental Content

Write to the Help Desk